- Home
- TRUG vs TLPH Comparison
TRUG vs TLPH Comparison
Compare TRUG & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- TLPH
- Stock Information
- Founded
- TRUG 1983
- TLPH 2005
- Country
- TRUG United States
- TLPH United States
- Employees
- TRUG N/A
- TLPH N/A
- Industry
- TRUG
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- TRUG
- TLPH Health Care
- Exchange
- TRUG NYSE
- TLPH Nasdaq
- Market Cap
- TRUG 7.0M
- TLPH 10.6M
- IPO Year
- TRUG N/A
- TLPH 2011
- Fundamental
- Price
- TRUG $5.90
- TLPH $0.47
- Analyst Decision
- TRUG Strong Buy
- TLPH Strong Buy
- Analyst Count
- TRUG 1
- TLPH 1
- Target Price
- TRUG $100.00
- TLPH $6.00
- AVG Volume (30 Days)
- TRUG 105.7K
- TLPH 44.5K
- Earning Date
- TRUG 08-13-2025
- TLPH 08-13-2025
- Dividend Yield
- TRUG N/A
- TLPH N/A
- EPS Growth
- TRUG N/A
- TLPH N/A
- EPS
- TRUG N/A
- TLPH N/A
- Revenue
- TRUG $22,236,072.00
- TLPH $27,000.00
- Revenue This Year
- TRUG $15.89
- TLPH N/A
- Revenue Next Year
- TRUG $40.93
- TLPH $14,533.26
- P/E Ratio
- TRUG N/A
- TLPH N/A
- Revenue Growth
- TRUG 8.40
- TLPH N/A
- 52 Week Low
- TRUG $5.15
- TLPH $0.43
- 52 Week High
- TRUG $73.50
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- TRUG 29.72
- TLPH 35.99
- Support Level
- TRUG $5.15
- TLPH $0.45
- Resistance Level
- TRUG $6.71
- TLPH $0.52
- Average True Range (ATR)
- TRUG 1.11
- TLPH 0.03
- MACD
- TRUG -0.37
- TLPH -0.01
- Stochastic Oscillator
- TRUG 16.76
- TLPH 11.11
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.